R. Fonte

3.8k citations

46 papers · 843 indexed · h-index 15

Impact in

Cancer Research
- MicroRNA in disease regulation
Immunology
- Immunotherapy and Immune Responses

Papers in

Nuclear and High Energy Physics 14
- Nuclear physics research studies 8
- Dark Matter and Cosmic Phenomena 4
- Astrophysics and Cosmic Phenomena 4
Radiation 8
- Nuclear Physics and Applications 7

Co-authors: Amalia Azzariti Letizia Porcelli Rosa Maria Iacobazzi Simona Serratì Nicola Silvestris Gabriella Guida Simona De Summa Michele Guida
Journals: Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment (4 papers)Cancers (4 papers)Nuclear Physics A (3 papers)Physics Letters B (3 papers)Scientific Reports (2 papers)
Partner nations: Italy United States France

In The Last Decade

R. Fonte

43 papers receiving 838 citations

Peers

Countries citing papers authored by R. Fonte

Since Specialization

Citations

This map shows the geographic impact of R. Fonte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Fonte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Fonte more than expected).

Fields of papers citing papers by R. Fonte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Fonte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Fonte. The network helps show where R. Fonte may publish in the future.

Co-authors

The 25 scholars most cited alongside R. Fonte, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. Fonte Line = papers co-authored together R. Fonte links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Developing a risk score using liquid biopsy biomarkers for selecting Immunotherapy responders and stratifying disease progression risk in metastatic melanoma patients Journal of Experimental & Clinical Cancer Research ·Amalia Azzariti, Simona De Summa, Tommaso Maria Marvulli, Ivana De Risi, Giuseppe De Palma, R. Fonte, Rossella Fasano, Simona Serratì, Sabino Strippoli, Letizia Porcelli, Michele Guida	2025	2
2	Unraveling vascular mechanisms in melanoma: roles of angiogenesis and vasculogenic mimicry in tumor progression and therapeutic resistance Cancer Biology and Medicine ·Simona Serratì, Lucia Raho, Gisella De Giosa, Letizia Porcelli, R. Fonte, Rossella Fasano, Pedro Miguel Lacal, Grazia Graziani, Rosa Maria Iacobazzi, Amalia Azzariti	2025	0
3	Small-Cell Lung Cancer: Is Liquid Biopsy a New Tool Able to Predict the Efficacy of Immunotherapy? Biomolecules ·Rossella Fasano, Simona Serratì, Tania Rafaschieri, Vito Longo, R. Fonte, Letizia Porcelli, Amalia Azzariti	2024	6
4	Fabrication of Biomimetic Hybrid Liposomes via Microfluidic Technology: Homotypic Targeting and Antitumor Efficacy Studies in Glioma Cells International Journal of Nanomedicine ·Ilaria Arduino, R. Fonte, Federica Sommonte, Angela Lopedota, Letizia Porcelli, Jiachen Li, Simona Serratì, Raquel Bártolo, Hélder A. Santos, Rosa Maria Iacobazzi, Amalia Azzariti, Nunzio Denora	2024	4
5	Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma Journal of Experimental & Clinical Cancer Research ·Simona Serratì, R. Fonte, Letizia Porcelli, Simona De Summa, Ivana De Risi, Livia Fucci, Eustachio Ruggieri, Tommaso Maria Marvulli, Sabino Strippoli, Rossella Fasano, Tania Rafaschieri, Gabriella Guida, Michele Guida, Amalia Azzariti	2023	18
6	Microfluidic development and biological evaluation of targeted therapy-loaded biomimetic nano system to improve the metastatic melanoma treatment International Journal of Pharmaceutics ·Ilaria Arduino, R. Fonte, Mattia Tiboni, Letizia Porcelli, Simona Serratì, Dafina Fondaj, Tania Rafaschieri, Annalisa Cutrignelli, Gabriella Guida, Luca Casettari, Amalia Azzariti, Angela Lopedota, Nunzio Denora, Rosa Maria Iacobazzi	2023	14
7	Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma Molecular Cancer ·Simona Serratì, Michele Guida, R. Fonte, Simona De Summa, Sabino Strippoli, Rosa Maria Iacobazzi, Alessandra Quarta, Ivana De Risi, Gabriella Guida, Angelo Paradiso, Letizia Porcelli, Amalia Azzariti	2022	116
8	BRAFV600E;K601Q metastatic melanoma patient-derived organoids and docking analysis to predict the response to targeted therapy Pharmacological Research ·Letizia Porcelli, R. Fonte, Ciro Leonardo Pierri, Livia Fucci, Concetta Saponaro, Andrea Armenio, Simona Serratì, Sabino Strippoli, Rossella Fasano, Mariateresa Volpicella, Rossana Daprile, Stefania Tommasi, Cosmo Maurizio Ressa, Michele Guida, Amalia Azzariti	2022	12
9	The Interaction between Reactive Peritoneal Mesothelial Cells and Tumor Cells via Extracellular Vesicles Facilitates Colorectal Cancer Dissemination Cancers ·Simona Serratì, Letizia Porcelli, Francesco Fragassi, Marianna Garofoli, R. Fonte, Livia Fucci, Rosa Maria Iacobazzi, Antonio J. Palazzo, Francesca Margheri, Grazia Cristiani, Anna Albano, Raffaele De Luca, Donato F. Altomare, M. De Simone, Amalia Azzariti	2021	11
10	Microfluidic-Assisted Preparation of Targeted pH-Responsive Polymeric Micelles Improves Gemcitabine Effectiveness in PDAC: In Vitro Insights Cancers ·Rosa Maria Iacobazzi, Ilaria Arduino, R. Fonte, Angela Lopedota, Simona Serratì, Giuseppe Francesco Racaniello, Viviana Bruno, Valentino Laquintana, Byung Chul Lee, Nicola Silvestris, Francesco Leonetti, Nunzio Denora, Letizia Porcelli, Amalia Azzariti	2021	19
11	Natural Bovine Coronavirus Infection in a Calf Persistently Infected with Bovine Viral Diarrhea Virus: Viral Shedding, Immunological Features and S Gene Variations Animals ·Annamaria Pratelli, Maria Stella Lucente, Marco Cordisco, Stefano Ciccarelli, R. Fonte, Alessio Sposato, Viviana Mari, Paolo Capozza, Francesco Pellegrini, Grazia Carelli, Amalia Azzariti, Canio Buonavoglia	2021	5
12	Hydroxy-Propil-β-Cyclodextrin Inclusion Complexes of two Biphenylnicotinamide Derivatives: Formulation and Anti-Proliferative Activity Evaluation in Pancreatic Cancer Cell Models International Journal of Molecular Sciences ·Rosa Maria Iacobazzi, Annalisa Cutrignelli, Angela Stefanachi, Letizia Porcelli, Angela Lopedota, R. Fonte, Antonio Lopalco, Simona Serratì, Valentino Laquintana, Nicola Silvestris, Massimo Franco, Saverio Cellamare, Francesco Leonetti, Amalia Azzariti, Nunzio Denora	2020	6
13	Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinib Biomedicine & Pharmacotherapy ·Letizia Porcelli, Annalisa Mazzotta, Marianna Garofoli, R. Fonte, Gabriella Guida, Michele Guida, Stefania Tommasi, Amalia Azzariti	2020	19
14	The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study Scientific Reports ·Letizia Porcelli, Marianna Garofoli, R. Fonte, Livia Fucci, Mariateresa Volpicella, Sabino Strippoli, Michele Guida, Amalia Azzariti	2020	27
15	Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells Scientific Reports ·Amalia Azzariti, Rosa Maria Iacobazzi, R. Fonte, Letizia Porcelli, Roberto Gristina, Pietro Favia, Francesco Fracassi, Ilaria Trizio, Nicola Silvestris, Gabriella Guida, Stefania Tommasi, Eloisa Sardella	2019	130
16	Synthesis and biological evaluation of N-biphenyl-nicotinic based moiety compounds: A new class of antimitotic agents for the treatment of Hodgkin Lymphoma Cancer Letters ·Letizia Porcelli, Diana A. Stolfa, Angela Stefanachi, R. Fonte, Marianna Garofoli, Rosa Maria Iacobazzi, Nicola Silvestris, Attilio Guarini, Saverio Cellamare, Amalia Azzariti	2018	9
17	Extrinsic Protein Tyrosine Phosphatase Non-Receptor 22 Signals Contribute to CD8 T Cell Exhaustion and Promote Persistence of Chronic Lymphocytic Choriomeningitis Virus Infection Frontiers in Immunology ·Tatiana Jofra, Giuseppe Galvani, Mirela Kuka, R. Fonte, Bechara Mfarrej, Matteo Iannacone, Shahram Salek‐Ardakani, Manuela Battaglia, Georgia Fousteri	2017	11
18	Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers International Journal of Pharmaceutics ·Rosa Maria Iacobazzi, Letizia Porcelli, Angela Lopedota, Valentino Laquintana, Antonio Lopalco, Annalisa Cutrignelli, Emiliano Altamura, R. Fonte, Amalia Azzariti, Massimo Franco, Nunzio Denora	2017	63
19	Lack of the protein tyrosine phosphatase PTPN22 strengthens transplant tolerance to pancreatic islets in mice Diabetologia ·Georgia Fousteri, Tatiana Jofra, R. Fonte, Nicola Gagliani, Cristina Morsiani, Angela Stabilini, Manuela Battaglia	2015	7
20	PTPN22 controls virally-induced autoimmune diabetes by modulating cytotoxic T lymphocyte responses in an epitope-specific manner Clinical Immunology ·Georgia Fousteri, Tatiana Jofra, R. Fonte, Mirela Kuka, Matteo Iannacone, Manuela Battaglia	2014	7

About R. Fonte

R. Fonte is a scholar working on Nuclear and High Energy Physics, Radiation, Immunology, Oncology and Biomaterials, having authored 46 papers that have together received 843 indexed citations. Recurring topics across this work include Nuclear physics research studies (8 papers), Nuclear Physics and Applications (7 papers), Diabetes and associated disorders (5 papers), Nanoparticle-Based Drug Delivery (4 papers), T-cell and B-cell Immunology (4 papers), Immunotherapy and Immune Responses (4 papers), Dark Matter and Cosmic Phenomena (4 papers) and Astrophysics and Cosmic Phenomena (4 papers). The work is most often cited by research in Cancer Research (143 citations), Immunology (178 citations), Oncology (224 citations), Biomaterials (66 citations) and Radiology, Nuclear Medicine and Imaging (113 citations). R. Fonte has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Amalia Azzariti, Letizia Porcelli, Rosa Maria Iacobazzi, Simona Serratì, Nicola Silvestris, Gabriella Guida, Simona De Summa, Michele Guida, Sabino Strippoli and Stefania Tommasi. Their work appears in journals such as Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment, Cancers, Nuclear Physics A, Physics Letters B and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact